IP Library Granted Patent US 8,425,955
Granted Patent B2
US 8,425,955 · App. 12/843,610 · Granted Apr 23, 2013

Nutritional composition with prebiotic component

Inventor: Anja Wittke (Evansville, IN)
Assignee: Mead Johnson Nutrition Company
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,425,955
App. No.
12/843,610
Granted
Apr 23, 2013
Kind
B2
Abstract

The present disclosure relates to nutritional compositions comprising a prebiotic component for inhibiting adherence of pathogens in the gastrointestinal tract of a subject and to the prebiotic component, which comprises galactooligosaccharide, polydextrose or any mixture thereof. The nutritional compositions of the present disclosure comprise a fat or lipid source, a protein source, and a carbohydrate source comprising an effective amount of the prebiotic component.

Claims (16)

1. A method for inhibiting adhesion of pathogens in the gastrointestinal tract of a human subject, comprising administering a nutritional composition which comprises:

(a) a prebiotic component, the prebiotic component comprising a galactooligosaccharide and polydextrose, wherein the combination of the galactooligosaccharide and polydextrose is present in an amount of between about 1.0 g/L and about 10.0 g/L of the nutritional composition; and

(b) at least one long chain polyunsaturated fatty acid in an amount of at least 5 mg/100 kcal of the nutritional composition.

2. The method according to claim 1 , wherein the ratio of polydextrose to galactooligosaccharide is between 9:1 and 1:9, wherein the ratio is determined based on the presence of each component in the nutritional composition in g/L.

3. The method according to claim 1 , further comprising the step of administering at least one probiotic.

4. The method according to claim 3 , wherein the probiotic is selected from the group consisting of Bifidobacteria spp., Lactobacillus spp. and a combination thereof.

5. The method according to claim 1 , wherein the long chain polyunsaturated fatty acid is selected from the group consisting of docosahexaenoic acid, arachidonic acid, and a combination thereof.

6. The method according to claim 1 , wherein the nutritional composition further comprises

a fat or lipid source; and

a protein source.

7. The method according to claim 6 , wherein the nutritional composition is an infant formula.

8. The method according to claim 7 , wherein the nutritional composition is nutritionally complete.

9. The method according to claim 1 , wherein the long chain polyunsaturated fatty acid is selected from the group consisting of docosahexaenoic acid, arachidonic acid, and a combination thereof.

10. The method according to claim 6 , wherein the fat or lipid source is present at a level of about 3 to about 7 g/100 kcal.

11. The method according to claim 6 , wherein the protein source is present at a level of about 1 to about 5 g/100 kcal.

12. The method according to claim 11 , wherein the protein source is selected from the group consisting of whey protein, casein, casein protein, nonfat milk, hydrolyzed protein and combinations thereof.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 3, 2015
From: MCMAHON, ROBERT J.
To: MEAD JOHNSON NUTRITION COMPANY
Reel/Frame 034879/0230 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 27, 2010
From: WITTKE, ANJA
To: MEAD JOHNSON NUTRITION COMPANY
Reel/Frame 024898/0417 →
Continuity (2)
Continuation In Part 12370141 · Feb 12, 2009
Related Publication 20100316619A1 · Dec 16, 2010